Concepedia

Publication | Open Access

Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG

DOIFull Paper Access

746

Citations

21

References

2006

Year

Jacobus Pfisterer, Marie Plante, Ignace Vergote, Andreas du Bois, Hal W. Hirte, Ángel J. Lacave, Uwe Wagner, Anne Stähle, Gavin Stuart, Rainer Kimmig,
Journal of Clinical Oncology

Abstract

Gemcitabine plus carboplatin significantly improves PFS and response rate without worsening quality of life for patients with platinum-sensitive recurrent ovarian cancer.

References

YearCitations

Page 1